ArticleAging clinical and experimental research2021

A novel effervescent formulation of oral weekly alendronate (70 mg) improves persistence compared to alendronate tablets in post-menopausal women with osteoporosis.

Andrea Giusti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.